176 related articles for article (PubMed ID: 204941)
21. The involvement of Lyt-2 antigens in the lysis of virus-infected target cells by antigen specific anti-vesicular stomatitis virus cytotoxic T-lymphocytes.
Hale AH
Immunol Lett; 1981 Aug; 3(3):179-81. PubMed ID: 6169636
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cell recognition of target cells expressing different antigens of vesicular stomatitis virus.
Moller JR; Rager-Zisman B; Quan PC; Schattner A; Panush D; Rose JK; Bloom BR
Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2456-9. PubMed ID: 2986117
[TBL] [Abstract][Full Text] [Related]
23. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells.
Black PL; Vitetta ES; Forman J; Kang CY; May RD; Uhr JW
Eur J Immunol; 1981 Jan; 11(1):48-55. PubMed ID: 6260509
[TBL] [Abstract][Full Text] [Related]
24. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
Sheil JM; Bevan MJ; Lefrancois L
J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
[TBL] [Abstract][Full Text] [Related]
25. Trojan horse lymphocytes: a vesicular stomatitis virus-specific T-cell clone lyses target cells by carrying virus.
Hom RC; Soman G; Finberg R
J Virol; 1989 Oct; 63(10):4157-64. PubMed ID: 2550662
[TBL] [Abstract][Full Text] [Related]
26. Reconstitution with T lymphocytes protects nude mice from a central nervous system disorder induced by a temperature-sensitive vesicular stomatitis virus.
Doll SC; Johnson TC
J Gen Virol; 1988 Aug; 69 ( Pt 8)():1969-77. PubMed ID: 2841409
[TBL] [Abstract][Full Text] [Related]
27. Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines.
Rosenthal KL; Zinkernagel RM; Hengartner H; Groscurth P; Dennert G; Takayesu D; Prevec L
J Virol; 1986 Nov; 60(2):539-47. PubMed ID: 3021987
[TBL] [Abstract][Full Text] [Related]
28. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.
Yewdell JW; Bennink JR; Mackett M; Lefrancois L; Lyles DS; Moss B
J Exp Med; 1986 Jun; 163(6):1529-38. PubMed ID: 3011949
[TBL] [Abstract][Full Text] [Related]
29. Effect of prostaglandins on elicitation of anti-viral-cytolytic activity.
Hale AH; Evans DL; Daniel LW
Immunol Lett; 1982 Mar; 4(3):171-4. PubMed ID: 6281179
[TBL] [Abstract][Full Text] [Related]
30. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
[TBL] [Abstract][Full Text] [Related]
31. Cell-mediated immunity to vesicular stomatitis virus infections in mice.
Zinkernagel RM; Adler B; Holland JJ
Exp Cell Biol; 1978; 46(1-2):53-70. PubMed ID: 202522
[TBL] [Abstract][Full Text] [Related]
32. Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes.
Hale AH; Ruebush MJ; Lyles DS; Harris DT
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6105-8. PubMed ID: 6255476
[TBL] [Abstract][Full Text] [Related]
33. Elicitation and specificity of anti-vesicular stomatitis virus-specific cytotoxic T lymphocytes.
Ruebush MJ; Hale AH; Lefrancois L; Harris DT; Burgess DE
J Immunol; 1981 May; 126(5):2053-9. PubMed ID: 6260862
[No Abstract] [Full Text] [Related]
34. Induction of protective cytotoxic T cells with viral proteins.
Bachmann MF; Kündig TM; Freer G; Li Y; Kang CY; Bishop DH; Hengartner H; Zinkernagel RM
Eur J Immunol; 1994 Sep; 24(9):2228-36. PubMed ID: 8088338
[TBL] [Abstract][Full Text] [Related]
35. Priming antiviral cytotoxic T lymphocytes: requirement for CD4+ cells is dependent on the antigen presenting cell in vivo.
Ciavarra RP; Tedeschi B
Cell Immunol; 1994 Aug; 157(1):132-43. PubMed ID: 7913664
[TBL] [Abstract][Full Text] [Related]
36. Replication-defective viruses modulate immune responses.
Browning MJ; Huneycutt BS; Huang AS; Reiss CS
J Immunol; 1991 Oct; 147(8):2685-91. PubMed ID: 1655896
[TBL] [Abstract][Full Text] [Related]
37. T cell hybridomas define the class II MHC-restricted response to vesicular stomatitis virus infection.
Petrarca MA; Reiss CS; Diamond DC; Boni J; Burakoff SJ; Faller DV
Microb Pathog; 1988 Nov; 5(5):319-32. PubMed ID: 2853279
[TBL] [Abstract][Full Text] [Related]
38. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?
Bachmann MF; Hengartner H; Zinkernagel RM
Eur J Immunol; 1995 Dec; 25(12):3445-51. PubMed ID: 8566036
[TBL] [Abstract][Full Text] [Related]
39. Cross-reactive cytotoxic T cells to serologically distinct vesicular stomatitis virus.
Rosenthal KL; Zinkernagel RM
J Immunol; 1980 May; 124(5):2301-8. PubMed ID: 6154097
[No Abstract] [Full Text] [Related]
40. The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.
Cobleigh MA; Bradfield C; Liu Y; Mehta A; Robek MD
J Virol; 2012 Apr; 86(8):4253-61. PubMed ID: 22345454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
